据ICIS-MRC网站5月11日莫斯科报道，据烃加工网信息显示，壳牌催化剂与技术公司（Shell Catalysts&Technologies即SC&T）和Arbios Biotech（Licella与Canfor的合资企业）结成了一个新的全球联盟，旨在利用SC&T的升级技术能力，追求低碳强度、以循环经济为重点的生物炼制。
Arbios Biotech成立的目的是将Licella的Cat HTR平台商业化，这是一种全球领先的水热液化（HTL）技术，用于世界各地，特别是北美、南美和欧洲各种形式的木材和消费后生物质。Cat-HTR使用近超临界水或超临界水来制造高质量的生物原油，这是一种可再生和可持续的循环经济生物油。
Arbios Biotech和SC&T之间的这一联盟预计，壳牌公司的升级装置将与商业Cat HTR工厂协同工作，这些工厂位于消费后生物质原料来源聚集区附近。通过将SC&T的升级装置与Cat-HTR工厂连接起来，Arbios Biotech公司将有能力在一个连续、高效的过程中将生物原油升级为成品。
郝芬 译自 ICIS-MRC
原文如下：
Shell forms alliance with Arbios Biotech in pursuit of a low-carbon intensity, circular-economy focused biorefinery
Shell Catalysts & Technologies and Arbios Biotech, a joint venture between Licella and Canfor, have formed a new global alliance aimed at utilizing SC&T’s upgrading technology capability in the pursuit of a low-carbon intensity, circular-economy focused biorefinery, according to Hydrocarbonprocessing.
Arbios Biotech was formed to commercialise Licella’s Cat-HTR platform, a globally leading hydrothermal liquefaction (HTL) technology, for various forms of wood and post-consumer biomass around the world, particularly in North America, South America and Europe. The Cat-HTR uses near or at supercritical water to create high-quality biocrude, a renewable and sustainable bio oil for the circular economy.
This alliance between Arbios Biotech and SC&T anticipates that Shell upgrader units will work in concert with commercial Cat-HTR plants, strategically located near aggregated post-consumer biomass feedstock sources. By linking SC&T upgrader units with Cat-HTR plants, Arbios Biotech would have the capability to upgrade biocrude to finished products in one continuous, efficient process.
免责声明：本网转载自其它媒体的文章，目的在于弘扬石化精神，传递更多石化信息，并不代表本网赞同其观点和对其真实性负责，在此我们谨向原作者和原媒体致以敬意。如果您认为本站文章侵犯了您的版权，请与我们联系，我们将第一时间删除。
